<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.edoktor.hr/lijekovi/fda-istrazuje-rizik-tumora-zolgensma-sma/</loc>
    <news:news>
      <news:publication>
        <news:name>eDoktor</news:name>
        <news:language>hr</news:language>
      </news:publication>
      <news:publication_date>2026-11-11T07:45:49+01:00</news:publication_date>
      <news:title>FDA istražuje rizik tumora kod gen-terapije Zolgensma</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.edoktor.hr/lijekovi/sunharbo-asundexian-fda-mozdani-udar/</loc>
    <news:news>
      <news:publication>
        <news:name>eDoktor</news:name>
        <news:language>hr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T15:49:27+01:00</news:publication_date>
      <news:title>FDA odobrila Sunharbo, prvi lijek nove vrste za moždani udar</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.edoktor.hr/lijekovi/ozempic-mounjaro-rizik-sljepila-naion/</loc>
    <news:news>
      <news:publication>
        <news:name>eDoktor</news:name>
        <news:language>hr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T09:46:34+01:00</news:publication_date>
      <news:title>Ozempic i Mounjaro dobivaju upozorenje o riziku sljepila</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.edoktor.hr/zdravlje/lijekovi-za-tlak-ulcerozni-kolitis-vedolizumab/</loc>
    <news:news>
      <news:publication>
        <news:name>eDoktor</news:name>
        <news:language>hr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T05:47:31+01:00</news:publication_date>
      <news:title>Lijekovi za tlak mogu poboljšati terapiju kolitisa</news:title>
    </news:news>
  </url>
</urlset>